Workshop IKNL
On behalf of Heart4Data, we are pleased to invite you to an inspiring workshop where we will explore how innovations from IKNL, such as R(H)ONDA and PLUGIN, provide valuable insights and applications that can also be relevant to the cardiological infrastructure being developed within Heart4Data and the DCVA data infrastructure pillar. During this session, experts […]
First inclusions REPEAT-AF: Start of the first national, registry-based randomised clinical trial
September saw the first inclusion for REPEAT-AF, an innovative study on the use of pulsed field ablation in reinterventions for atrial fibrillation (AF). This marks a new milestone in cardiovascular clinical research: it is the first registration-based, randomised clinical trial (RB-RCT) in Dutch cardiology. ‘So far, we have included 20 patients and we find that, […]
Invite: Seminar SELEQT-HF
Can intervention with Q10 and selenium slow down the ageing process, prevent cardiovascular disease and improve quality of life? An investigator meeting will be organised for SELEQT-HF in collaboration with Pharma Nord on Tuesday evening 4 February 2025 from 17:00. SELEQT-HF is the first registration-based randomised controlled trial within the Heart4Data consortium of the DCVA. […]
The Dutch Heart Foundation announces goals and ambitions national cardiovascular agenda
Over ten thousand Dutch people gave their opinions on it. And another hundred researchers, healthcare providers and patients contributed their expertise to it: the national cardiovascular agenda. Today, the Dutch Heart Foundation announces its ambitions and goals. The aim of Heart4Data, developing a sustainable infrastructure for registry-based research, aligns well with this: particularly in the […]
Follow-up period of 20 years thanks to innovative data linking
One of the goals of Heart4Data is to create links between various data sources (See workpackage 6) and the NHR registration for heart failure. For example, the link with Central Bureau of Statistics microdata. This research by Yvonne Koop et al, the Octopus Follow-Up study, has implemented and tested this link. The Octopus follow-up study […]
Fellowship call 2024: announcement winners & pitches
Elementor #653 11/07/2024 We are very pleased our first Heart4Data fellowship call has started. This program is an opportunity to develop research skills in registry-based research, particularly concerning data linkage, on the topic of heart failure and atrium fibrillation in the Netherlands as they move forward in their career. Three award-winning project proposals have been […]
Heart4Data: Update SELEQT-HF and EPD-based registration Heart failure
Thursday, April 7, an update was given on the progress of RB-RCT research on Heart4Data’s infrastructure. Interest in this webinar was evidenced by the high attendance and responses. The following speakers and topics were covered: SELEQT-HF Setting up a heart failure care pathway This webinar was recorded and can be viewed on request. Would you […]
Heart4Data: recap consortium meeting February 7th 2024
💡 On Wednesday, the 7th of February 2024 a consortium meeting of Heart4Data took place. Did you miss this meeting? Read all about the progress made developing a sustainable infrastructure for cardiovascular research in the recap (in Dutch), like: Heart4Data is initiated and funded by the Dutch Heart Foundation and ZonMw, and supported by the […]
Explanation animation Heart4Data
Recently released: An animated video introducing Heart4Data, the DCVA consortium focused on establishing a sustainable infrastructure for cardiovascular registry-based research in the Netherlands. The video offers an overview of its organisational framework and objectives and is available in both Dutch and English language.
Heart4Data: Consortium agreement SELEQT-HF
A big milestone for Heart4Data: On June 1, 2023, the consortium agreement for the SELEQT-HF research project was signed! This project is a collaboration between ZonMw, Netherlands Heart Institute, NHR, Dutch CardioVascular Alliance, WCN, Harteraad, NVVC, Health-RI, NVT, Pharma Nord, Zuyderland, Erasmus MC, UMCG & Amsterdam UMC. Principal investigators Jeroen Schaap and Peter van der […]